Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix
- 1 October 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 382 (9899), 1214-1223
- https://doi.org/10.1016/s0140-6736(13)61897-8
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Novel Molecular Therapies for Heritable Skin DisordersJournal of Investigative Dermatology, 2012
- Harnessing the potential of induced pluripotent stem cells for regenerative medicineNature, 2011
- Revertant mosaicism in skin: natural gene therapyTrends in Molecular Medicine, 2011
- Dynamics between Stem Cells, Niche, and Progeny in the Hair FollicleCell, 2011
- SIN Retroviral Vectors Expressing COL7A1 Under Human Promoters for Ex Vivo Gene Therapy of Recessive Dystrophic Epidermolysis BullosaMolecular Therapy, 2010
- Mechanisms of Fibroblast Cell Therapy for Dystrophic Epidermolysis Bullosa: High Stability of Collagen VII Favors Long-term Skin IntegrityMolecular Therapy, 2009
- Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing ParadigmsMolecular Therapy, 2009
- Injection of Recombinant Human Type VII Collagen Corrects the Disease Phenotype in a Murine Model of Dystrophic Epidermolysis BullosaMolecular Therapy, 2009
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001